IPO registrations (S-1, F-1) · Registrants
SEQUENOM INC
- SEC CIK
- 1076481 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1999-11-24, last 2000-01-28; 1 initial registration, 6 amendments
- Outcome
- Final prospectus filed 2000-02-01
- Industry (SIC)
- Measuring & Controlling Devices, NEC 3829
- Incorporated in
- DE
- Business address
- 3595 JOHN HOPKINS COURT, San Diego, X1 92121
- EIN
- 77-0365889
- EDGAR entity type
- operating
- Insiders and CEO pay
- SEQUENOM INC on the corporate pages
Offering terms
- Proposed price range
- $23.00–$25.00 per share (S-1/A filed 2000-01-28)
- Final price
- $26.00 per share, above the range (424B4 filed 2000-02-01, an initial public offering)
- Shares sold
- 57,564
- Gross proceeds
- $1,496,664 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol SQNM
- Lead underwriters
- UBS
- Syndicate
- Robertson Stephens; Cowen; Personalized Medicine; Drug Development; the Total; High Throughput; Industrial Genomics
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: SEQUENOM, INC. EXACT (EIN (EXACT))
- Form D issuer: SEQUENOM INC EXACT (CIK (EXACT))
- SEC filer: SEQUENOM INC EXACT (CIK (EXACT))
- Person page: Catherine J Mackey Phd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Harry F Hixson Jr Phd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Kenneth F Buechler Phd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Richard A Lerner Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1999-11-24 | S-1 | S-1 (registration) | SEQUENOM INC | 0001072993-99-000328 ↗ |
| 1999-12-07 | S-1/A | S-1/A (amendment) | SEQUENOM INC | 0001072993-99-000341 ↗ |
| 2000-01-03 | S-1/A | S-1/A (amendment) | SEQUENOM INC | 0001021408-00-000003 ↗ |
| 2000-01-06 | S-1/A | S-1/A (amendment) | SEQUENOM INC | 0001072993-00-000012 ↗ |
| 2000-01-24 | S-1/A | S-1/A (amendment) | SEQUENOM INC | 0001072993-00-000032 ↗ |
| 2000-01-28 | S-1/A | S-1/A (amendment) | SEQUENOM INC | 0000898430-00-000210 ↗ |
| 2000-01-28 | S-1/A | S-1/A (amendment) | SEQUENOM INC | 0001072993-00-000037 ↗ |
| 2000-02-01 | S-1MEF | S-1MEF (added securities) | SEQUENOM INC | 0000898430-00-000236 ↗ |
| 2000-02-01 | 424B4 | 424B4 (final prospectus) | SEQUENOM INC | 0001072993-00-000057 ↗ |
| 2000-02-01 | 424B4 | 424B4 (final prospectus) | SEQUENOM INC | 0001072993-00-000058 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-01-28 | S-1/A | registration statement | $23.00–$25.00 | 5,817,826 | - | Nasdaq SQNM | 8 | from the submission text; range, shares headline, cover names 8 | document ↗ | |
| 2000-02-01 | 424B4 | final prospectus | $26.00 | 57,564 | $1,496,664 | Nasdaq SQNM | 0 | from the submission text; price sentence, shares headline, proceeds table | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| COMMONWEALTH ASSOCIATES LP | TenPercentOwner | 1 | 2006 | ||
| COMVEST INVESTMENT PARTNERS II LLC | TenPercentOwner | 5 | 2006–2007 | ||
| FALK MICHAEL | TenPercentOwner | 5 | 2006–2007 | ||
| PEQUOT CAPITAL MANAGEMENT INC | DirectorOther; Other | 4 | 2006–2007 | ||
| PRIDDY ROBERT L | TenPercentOwner | 5 | 2006–2007 | ||
| Dragon Elizabeth | Officer | Sr VP, Research & Development; Sr. VP, Research & Development | 7 | 2006–2009 | |
| AFTING ERNST-GUENTER | Director | 16 | 2006–2013 | ||
| CANTOR CHARLES R | Director,Officer; Officer | Chief Scientific Officer | 14 | 2006–2013 | |
| ENRIGHT PATRICK G | Director | 5 | 2006–2007 | ||
| HIXSON HARRY F JR | Director; Director,Officer | CEO; Interim CEO | 21 | 2006–2015 | person page Fuzzy |
| LENIG LARRY E JR | Director | 2 | 2006 | ||
| LINDSAY RONALD M | Director; Director,Officer | Executive VP, R&D; Exec VP, R&D; Interim Senior VP of R&D; Sr VP, R&D | 28 | 2006–2016 | |
| LUCASJOHN | Director | 1 | 2006 | ||
| Neumann Clarke | Officer | VP and General Counsel; VP & General Counsel | 22 | 2006–2012 | |
| Sharp John P | Officer | Treasurer; VP Finance | 2 | 2006–2007 | |
| Stylli Harry | Director,Officer | President and CEO | 17 | 2006–2009 | |
| SIEMENS AKTIENGESELLSCHAFT | Other; TenPercentOwner | 2 | 2006–2008 | ||
| Siemens Venture Capital GmbH | Other; TenPercentOwner | 2 | 2006–2008 | ||
| LEHMAN BROTHERS HOLDINGS INC | TenPercentOwner | 6 | 2006–2008 | ||
| HAWRAN PAUL W | Director; Officer | Chief Financial Officer | 17 | 2006–2009 | |
| MONKO ALEXANDER MICHAEL | Officer | Sr. VP, Genetic Analysis; Sr VP, Sales & Marketing | 20 | 2006–2014 | |
| ComVest Group Holdings, LLC | TenPercentOwner | 4 | 2006–2007 | ||
| KARSTEN SCHMIDT | Officer | VP Business Development; VP, Business Development | 9 | 2007–2010 | |
| MYRES LARRY | Officer | VP, Operations | 18 | 2007–2011 | |
| TATMAN DERECK | Officer | VP, Business Development | 6 | 2007–2009 | |
| OWINGS STEVE | Officer | VP Commercial Development; VP Ops, Prenatal Diagnostics | 6 | 2007–2009 | |
| Wiltsey Kathleen M | Director | 6 | 2007–2010 | ||
| LERNER RICHARD A | Director | 18 | 2007–2016 | person page Fuzzy | |
| FAZIO JOHN A | Director | 28 | 2007–2014 | ||
| ALDRICH RICHARD | TenPercentOwner | 13 | 2008 | ||
| Kolchinsky Peter | TenPercentOwner | 13 | 2008 | ||
| RA Capital Biotech Fund II, L.P. | TenPercentOwner | 13 | 2008 | ||
| RA Capital Biotech Fund LP | TenPercentOwner | 13 | 2008 | ||
| RA CAPITAL MANAGEMENT, LLC | TenPercentOwner | 13 | 2008 | ||
| Ridgeback Capital Investments L.P. | TenPercentOwner | 15 | 2008–2009 | ||
| Ridgeback Capital Investments Ltd. | TenPercentOwner | 15 | 2008–2009 | ||
| Ridgeback Capital Management LLC | TenPercentOwner | 15 | 2008–2009 | ||
| RIORDAN GARY | Officer | VP, Reg Affairs & Quality | 3 | 2008–2009 | |
| BOMBARD ALLAN | Officer | Chief Medical Officer | 13 | 2009–2014 | |
| FILE JUSTIN J | Officer | Principal Acctg & Fncl Ofcr | 1 | 2009 | |
| JUDGE ALISA | Officer | VP Human Resources; VP, Human Resources | 10 | 2009–2013 | |
| MARCELL SHAWN M | Officer | VP, Molecular Diag, Oncol | 2 | 2009 | |
| MAIER PAUL V | Officer | Chief Financial Officer; Interim CFO | 19 | 2009–2014 | |
| BUECHLER KENNETH F | Director | 19 | 2009–2016 | person page Fuzzy | |
| PENDARVIS DAVID | Director | 17 | 2009–2016 | ||
| ZIMMERMAN JOSEPH | Officer | VP & General Manager, SCMM | 2 | 2010 | |
| VAN DEN BOOM DIRK | Director,Officer; Officer | CSO; CSSO; Director, Mol Biology; EVP & Chief Tech Ofcr; EVP & Chief Tech. Officer; EVP, CSSO; EVP, R&D & CTO; President & CEO; Sr. VP, R&D; Sr VP, Research & Development | 22 | 2010–2016 | |
| WEINER ROBIN | Officer | Sr VP Corp Gov & Reg Affairs; Sr VP Reg Affairs & Quality; Sr. VP, Reg Affairs & Quality; Sr VP Regulatory & Quality; SVP Corp Gov & Reg Affairs | 11 | 2010–2016 | |
| WELCH WILLIAM J | Officer | CEO; President & CEO; President & COO; Sr. VP, Diagnostics | 12 | 2011–2015 | |
| SLACIK CHARLES P | Director | 15 | 2011–2016 | ||
| BEAVER CAROLYN | Officer | CFO; SVP & CFO; VP and Chief Accounting Ofcr; VP and Chief Accounting Office; VP & Chief Accounting Officer | 17 | 2012–2016 | |
| LAI GOLDMAN MYLA | Director | 12 | 2012–2016 | ||
| BOWEN R WILLIAM | Officer | Sr. VP and General Counsel; Sr VP & General Counsel | 6 | 2012–2014 | |
| LINTON JEFFREY D | Officer | Sr VP, GC & Secretary; Sr VP & General Counsel | 10 | 2014–2016 | |
| GROSU DANIEL S MD | Officer | SVP & CMO | 6 | 2015–2016 | |
| MACKEY CATHERINE J | Director | 5 | 2015–2016 | person page Fuzzy | |
| Camber Capital Management LLC | TenPercentOwner | 6 | 2015–2016 | ||
| LOZUK ROBERT | Officer | SVP, Commercial Ops; SVP, Commercial Ops | 5 | 2016 | |
| EBERTS F SAMUEL III | Director,Officer | Chairman, President & Sec | 1 | 2016 | |
| EISENBERG GLENN A | Director,Officer | EVP and Treasurer | 1 | 2016 | |
| HAAS WILLIAM | Director | 1 | 2016 | ||
| LABORATORY CORP OF AMERICA HOLDINGS | TenPercentOwner | 2 | 2016 | ||
| Miller Benjamin R | Director | 1 | 2016 | ||
| van der Vaart Sandra D | Director | 1 | 2016 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-06-19 | SEQUENOM INC | Biotechnology | $85,000,000 | $85,000,000 | 10 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | SEQUENOM, INC. | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | SEQUENOM INC | Form D private offerings | CIK (EXACT) | |
| SEC filer | SEQUENOM INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | SEQUENOM, INC. | EIN (EXACT) | ||
| Person page | Catherine J Mackey Phd | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Harry F Hixson Jr Phd | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Kenneth F Buechler Phd | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Richard A Lerner | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Measuring & Controlling Devices, NEC, X1 first:
- GEOSPACE TECHNOLOGIES CORP TX
- GEOSCIENCE CORP TX
- ONIX SYSTEMS INC TX
- ACLARA BIOSCIENCES INC CA
- ACCEL BRANDS, INC. MD
- RAE SYSTEMS INC CA
- XENOGEN CORP CA
- PRIVIAM, INC. CA
- DRESSER INC TX
- ION TRACK INC MA
In other datasets, the same topic (Technology) in X1:
- Form D issuer: Adtile Technologies Inc. (Form D private offerings)
Interests: Measuring & Controlling Devices, NEC · Technology